Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 19, 2023

SELL
$239.75 - $277.0 $116,278 - $134,345
-485 Reduced 33.96%
943 $237,000
Q4 2022

Jan 18, 2023

BUY
$241.42 - $282.29 $127,469 - $149,049
528 Added 58.67%
1,428 $0
Q3 2022

Oct 31, 2022

SELL
$247.06 - $1507.4 $30,388 - $185,410
-123 Reduced 12.02%
900 $232,000
Q2 2022

Jul 12, 2022

SELL
$237.11 - $299.66 $131,596 - $166,311
-555 Reduced 35.17%
1,023 $259,000
Q1 2022

Apr 12, 2022

SELL
$257.27 - $315.76 $61,230 - $75,150
-238 Reduced 13.11%
1,578 $463,000
Q4 2021

Jan 13, 2022

BUY
$292.08 - $329.01 $44,980 - $50,667
154 Added 9.27%
1,816 $597,000
Q3 2021

Nov 05, 2021

BUY
$272.21 - $332.43 $66,419 - $81,112
244 Added 17.21%
1,662 $506,000
Q2 2021

Aug 11, 2021

SELL
$225.08 - $271.69 $15,080 - $18,203
-67 Reduced 4.51%
1,418 $381,000
Q1 2021

May 03, 2021

BUY
$212.38 - $245.9 $19,963 - $23,114
94 Added 6.76%
1,485 $334,000
Q4 2020

Jan 25, 2021

SELL
$212.5 - $245.46 $44,200 - $51,055
-208 Reduced 13.01%
1,391 $309,000
Q3 2020

Oct 30, 2020

BUY
$177.16 - $215.33 $24,270 - $29,500
137 Added 9.37%
1,599 $344,000
Q2 2020

Aug 10, 2020

BUY
$128.7 - $176.83 $188,159 - $258,525
1,462 New
1,462 $259,000
Q1 2020

Apr 30, 2020

SELL
$121.39 - $169.05 $234,039 - $325,928
-1,928 Closed
0 $0
Q4 2019

Feb 03, 2020

SELL
$133.47 - $153.48 $210,348 - $241,884
-1,576 Reduced 44.98%
1,928 $296,000
Q3 2019

Nov 07, 2019

BUY
$135.4 - $146.47 $40,484 - $43,794
299 Added 9.33%
3,504 $506,000
Q2 2019

Jul 09, 2019

BUY
$124.88 - $143.73 $400,240 - $460,654
3,205 New
3,205 $458,000
Q1 2018

Apr 17, 2018

SELL
$92.16 - $103.8 $105,891 - $119,266
-1,149 Closed
0 $0
Q4 2017

Feb 05, 2018

BUY
$85.26 - $94.62 $97,963 - $108,718
1,149
1,149 $114,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Calton & Associates, Inc. Portfolio

Follow Calton & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Calton & Associates, Inc. with notifications on news.